Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation

Introduction: Post-transplant diabetes mellitus (PTDM) is a known side effect in transplant recipients administered immunosuppressant drugs, such as tacrolimus. This study aimed to investigate the risk factors related to PTDM, and establish a risk prediction model for PTDM. In addition, we explored...

Full description

Bibliographic Details
Main Authors: Fang Cheng, Qiang Li, Jinglin Wang, Zhendi Wang, Fang Zeng, Yu Zhang
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016422001463
_version_ 1818023384068390912
author Fang Cheng
Qiang Li
Jinglin Wang
Zhendi Wang
Fang Zeng
Yu Zhang
author_facet Fang Cheng
Qiang Li
Jinglin Wang
Zhendi Wang
Fang Zeng
Yu Zhang
author_sort Fang Cheng
collection DOAJ
description Introduction: Post-transplant diabetes mellitus (PTDM) is a known side effect in transplant recipients administered immunosuppressant drugs, such as tacrolimus. This study aimed to investigate the risk factors related to PTDM, and establish a risk prediction model for PTDM. In addition, we explored the effect of PTDM on the graft survival rate of kidney transplantation recipients. Methods: Patients with pre-diabetes mellitus before kidney transplant were excluded, and 495 kidney transplant recipients were included in our study, who were assigned to the non-PTDM and PTDM groups. The cumulative incidence was calculated at 3 months, 6 months, 1 year, 2 years, and 3 years post-transplantation. Laboratory tests were performed and the tacrolimus concentration, clinical prognosis, and adverse reactions were analyzed. Furthermore, binary logistic regression analysis was used to identify the independent risk factors of PTDM. Results: Age ≥ 45 years (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 1.14–3.92; P = 0.015), body mass index (BMI) > 25 kg/m2 (aOR 3.12, 95% CI 2.29–5.43, P < 0.001), tacrolimus concentration > 10 ng/mL during the first 3 months post-transplantation (aOR 2.46, 95%CI 1.41–7.38; P < 0.001), transient hyperglycemia (aOR 4.53, 95% CI 1.86–8.03; P < 0.001), delayed graft function (DGF) (aOR 1.31, 95% CI 1.05–2.39; P = 0.019) and acute rejection (aOR 2.16, 95% CI 1.79–4.69; P = 0.005) were identified as independent risk factors of PTDM. The PTDM risk prediction model was developed by including the above six risk factors, and the area under the receiver operating characteristic curve was 0.916 (95% CI 0.862–0.954, P < 0.001). Furthermore, the cumulative graft survival rate was significantly higher in the non- PTDM group than in the PTDM group. Conclusions: Risk factors related to PTDM were age ≥ 45 years, BMI > 25 kg/m2, tacrolimus concentration > 10 ng/mL during the first 3 months post-transplantation, transient hyperglycemia, DGF and acute rejection.
first_indexed 2024-12-10T03:43:27Z
format Article
id doaj.art-adf20ac5597d49ce98c363a107cade2e
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-12-10T03:43:27Z
publishDate 2022-08-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-adf20ac5597d49ce98c363a107cade2e2022-12-22T02:03:30ZengElsevierSaudi Pharmaceutical Journal1319-01642022-08-0130810881094Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantationFang Cheng0Qiang Li1Jinglin Wang2Zhendi Wang3Fang Zeng4Yu Zhang5Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, ChinaDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, ChinaDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, ChinaDepartment of Urology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China; Corresponding authors at: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan 430022, China; Corresponding authors at: Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.Introduction: Post-transplant diabetes mellitus (PTDM) is a known side effect in transplant recipients administered immunosuppressant drugs, such as tacrolimus. This study aimed to investigate the risk factors related to PTDM, and establish a risk prediction model for PTDM. In addition, we explored the effect of PTDM on the graft survival rate of kidney transplantation recipients. Methods: Patients with pre-diabetes mellitus before kidney transplant were excluded, and 495 kidney transplant recipients were included in our study, who were assigned to the non-PTDM and PTDM groups. The cumulative incidence was calculated at 3 months, 6 months, 1 year, 2 years, and 3 years post-transplantation. Laboratory tests were performed and the tacrolimus concentration, clinical prognosis, and adverse reactions were analyzed. Furthermore, binary logistic regression analysis was used to identify the independent risk factors of PTDM. Results: Age ≥ 45 years (adjusted odds ratio [aOR] 2.25, 95% confidence interval [CI] 1.14–3.92; P = 0.015), body mass index (BMI) > 25 kg/m2 (aOR 3.12, 95% CI 2.29–5.43, P < 0.001), tacrolimus concentration > 10 ng/mL during the first 3 months post-transplantation (aOR 2.46, 95%CI 1.41–7.38; P < 0.001), transient hyperglycemia (aOR 4.53, 95% CI 1.86–8.03; P < 0.001), delayed graft function (DGF) (aOR 1.31, 95% CI 1.05–2.39; P = 0.019) and acute rejection (aOR 2.16, 95% CI 1.79–4.69; P = 0.005) were identified as independent risk factors of PTDM. The PTDM risk prediction model was developed by including the above six risk factors, and the area under the receiver operating characteristic curve was 0.916 (95% CI 0.862–0.954, P < 0.001). Furthermore, the cumulative graft survival rate was significantly higher in the non- PTDM group than in the PTDM group. Conclusions: Risk factors related to PTDM were age ≥ 45 years, BMI > 25 kg/m2, tacrolimus concentration > 10 ng/mL during the first 3 months post-transplantation, transient hyperglycemia, DGF and acute rejection.http://www.sciencedirect.com/science/article/pii/S1319016422001463Kidney transplantationPost-transplant diabetes mellitusRisk factorsTacrolimusGraft loss
spellingShingle Fang Cheng
Qiang Li
Jinglin Wang
Zhendi Wang
Fang Zeng
Yu Zhang
Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
Saudi Pharmaceutical Journal
Kidney transplantation
Post-transplant diabetes mellitus
Risk factors
Tacrolimus
Graft loss
title Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
title_full Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
title_fullStr Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
title_full_unstemmed Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
title_short Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation
title_sort analysis of risk factors and establishment of a risk prediction model for post transplant diabetes mellitus after kidney transplantation
topic Kidney transplantation
Post-transplant diabetes mellitus
Risk factors
Tacrolimus
Graft loss
url http://www.sciencedirect.com/science/article/pii/S1319016422001463
work_keys_str_mv AT fangcheng analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation
AT qiangli analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation
AT jinglinwang analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation
AT zhendiwang analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation
AT fangzeng analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation
AT yuzhang analysisofriskfactorsandestablishmentofariskpredictionmodelforposttransplantdiabetesmellitusafterkidneytransplantation